3 Results for "

LDN211904

" in MedChemExpress (MCE) Product Catalog:
Products (3)

3 Results for "LDN211904" in MCE Product Catalog:

Cat. No.: HY-136358
CAS No.: 1198408-39-7
Target:  

Ephrin Receptor

Research Areas:  

Cancer

LDN-211904 is a potent and reversible EphB3 inhibitor with an IC50 of 79 nM. LDN-211904 shows good metabolic stability in mouse liver microsomes. LDN-211904 with cetuximab could be effective in inhibiting STAT3-activated colorectal cancer (CRC) stemness and Cetuximab (HY-P9905) resistance in CRC .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-107460
CAS No.: 1198408-78-4
Purity:  ≥99.0%
Target:  

Ephrin Receptor

Research Areas:  

Cancer

LDN-211904 oxalate is a potent and reversible EphB3 inhibitor with an IC50 of 79 nM. LDN-211904 oxalate shows good metabolic stability in mouse liver microsomes. LDN-211904 oxalate with Cetuximab (HY-P9905) could be effective in inhibiting STAT3-activated colorectal cancer (CRC) stemness and Cetuximab resistance in CRC .
loading...
    loading...
Cat. No.: HY-107460R
CAS No.: 1198408-78-4
Research Areas:  

Cancer

LDN-211904 oxalate (Standard) is the analytical standard of LDN-211904 (oxalate) (HY-107460). This product is intended for research and analytical applications. LDN-211904 oxalate is a potent and reversible EphB3 inhibitor with an IC50 of 79 nM. LDN-211904 oxalate shows good metabolic stability in mouse liver microsomes. LDN-211904 oxalate with Cetuximab (HY-P9905) could be effective in inhibiting STAT3-activated colorectal cancer (CRC) stemness and Cetuximab resistance in CRC .
loading...
    loading...